Sky Pharma
Sendai, Miyagi, Japan
About Sky Pharma
Sky Pharma is a developer of regenerative medicines for ophthalmology diseases and spinal cord injuries. They provide the development of regenerative medicine using low molecular-size compounds for the production of biological compounds from IPS cells and other materials for the treatment of glaucoma and spinal cord injury. They engage in the clinical development of drug discovery seeds developed by a unique methodology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Last round: Series Unknown (Nov 2020)
- Website: sky-pharma.neten
- Phone: +81 022-398-6635
Industries & Categories
Biotechnology, Manufacturing, Pharmaceutical
Canonical: https://fsome.com/organization/sky-pharma-2567495 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.